Moreover, our data provide proof‐of‐concept evidence that targeting titin‐based VSMC tone through the RBM20‐titin axis may be beneficial for the treatment of cardiovascular diseases caused by or involving increased peripheral vascular resistance. Here, TTN is linked to cardiovascular disorder.